(Q52028351)

20 April 2018

title

Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats. (English)

1 reference

20 April 2018

author

Paul R. Carlier

4

1 reference

20 April 2018

Yuan-Ping Pang

5

1 reference

20 April 2018

Yifan Han

6

1 reference

20 April 2018

author name string

J Liu

1

1 reference

20 April 2018

W Ho

2

1 reference

20 April 2018

N T Lee

3

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

20 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

20 April 2018

volume

282

1 reference

20 April 2018

issue

3

1 reference

20 April 2018

page(s)

165-168

1 reference

20 April 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

The AF64A model of cholinergic hypofunction: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Behavioral and neurochemical effects of intraventricular AF64A administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

Huperzine A ameliorates the spatial working memory impairments induced by AF64A.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900905-8

7 January 2021

10.1016/S0304-3940(00)00905-8

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018